Editas Medicine Inc’s recently made public that its EVP, CHIEF SCIENTIFIC OFFICER Burkly Linda unloaded Company’s shares for reported $12757.0 on Jul 31 ’25. In the deal valued at $2.49 per share,5,121 shares were sold. As a result of this transaction, Burkly Linda now holds 64,398 shares worth roughly $0.16 million.
Then, Burkly Linda bought 7,500 shares, generating $25,950 in total proceeds.
Before that, Parison Amy sold 446 shares. Editas Medicine Inc shares valued at $769 were divested by the SVP, Chief Financial Officer at a price of $1.72 per share. As a result of the transaction, Parison Amy now holds 17,506 shares, worth roughly $44815.36.
H.C. Wainwright initiated its Editas Medicine Inc [EDIT] rating to a Buy in a research note published on April 28, 2025; the price target was $3. A number of analysts have revised their coverage, including JP Morgan’s analysts, who decreased its forecast for the stock in mid December from “a Neutral” to “an Underweight”. Truist also remained covering EDIT and has decreased its forecast on December 13, 2024 with a “Hold” recommendation from previously “Buy” rating. Stifel revised its rating on December 13, 2024. It rated EDIT as “a Hold” which previously was an “a Buy”.
Price Performance Review of EDIT
On Monday, Editas Medicine Inc [NASDAQ:EDIT] saw its stock jump 4.92% to $2.56. Over the last five days, the stock has lost -13.51%. Editas Medicine Inc shares have fallen nearly -52.68% since the year began. Nevertheless, the stocks have risen 101.57% over the past one year.
How much short interest is there in Editas Medicine Inc?
A steep rise in short interest was recorded in Editas Medicine Inc stocks on 2025-07-15, growing by 89826.0 shares to a total of 8.52 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 8.43 million shares. There was a rise of 1.05%, which implies that there is a positive sentiment for the stock.
